Addition of thalidomide (t) to oral melphalan/prednisone (mp) in patients with multiple myeloma: Initial results of a randomized trial from the Turkish myeloma study group.
dc.contributor.author | Beksaç, Mehmet Sinan | |
dc.contributor.author | Haznedar, Rauf | |
dc.contributor.author | Fıratlı, Tülin Tuğlular | |
dc.contributor.author | Özdoğu, Hakan | |
dc.contributor.author | Aydoğdu, İsmet | |
dc.contributor.author | Konuk, Nahide | |
dc.contributor.author | Sucak, Gulşan Ayhan | |
dc.contributor.author | Kaygusuz, Işık | |
dc.contributor.author | Karakuş, Savaş | |
dc.contributor.author | Kaya, Emin | |
dc.contributor.author | Gülbaş, Zafer | |
dc.contributor.author | Özet, Gülsüm | |
dc.contributor.author | Göker, Hakan | |
dc.contributor.author | Ündar, Levent | |
dc.contributor.buuauthor | Ali, Rıdvan | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Hematoloji Anabilim Dalı. | tr_TR |
dc.date.accessioned | 2022-06-09T06:54:23Z | |
dc.date.available | 2022-06-09T06:54:23Z | |
dc.date.issued | 2009-11-20 | |
dc.description | Bu çalışma, 05-08 Aralık 2009 tarihleri arasında New Orleans[Luisana]’da düzenlenen düzenlenen 51. Annual Meeting of the American-Society-of-Hematology’da bildiri olarak sunulmuştur. | tr_TR |
dc.description.sponsorship | Amer Soc Hematol | en_US |
dc.identifier.citation | Beksaç, M. vd. (2009). "Addition of thalidomide (t) to oral melphalan/prednisone (mp) in patients with multiple myeloma: Initial results of a randomized trial from the Turkish myeloma study group". Blood, 114(22), 746-747. | en_US |
dc.identifier.endpage | 747 | tr_TR |
dc.identifier.issn | 0006-4971 | |
dc.identifier.issue | 22 | tr_TR |
dc.identifier.startpage | 746 | tr_TR |
dc.identifier.uri | http://hdl.handle.net/11452/26995 | |
dc.identifier.volume | 114 | tr_TR |
dc.identifier.wos | 000272725802248 | |
dc.indexed.wos | SCIE | en_US |
dc.indexed.wos | CPCIS | en_US |
dc.language.iso | en | en_US |
dc.publisher | Amer Soc Hematology | en_US |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.relation.journal | Blood | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Hematology | en_US |
dc.subject.wos | Hematology | en_US |
dc.title | Addition of thalidomide (t) to oral melphalan/prednisone (mp) in patients with multiple myeloma: Initial results of a randomized trial from the Turkish myeloma study group. | en_US |
dc.type | Meeting Abstract | |
dc.wos.quartile | Q1 | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: